Investors in Healthcare Trust, Inc. may have FINRA arbitration claims, if their investment was recommended by a financial advisor who lacked a reasonable basis for the recommendation, or if the nature of the investment was misrepresented by the stockbroker or advisor.
According to filings with the SEC, on April 3, 2020, Healthcare Trust announced that its board of directors announced an estimated NAV per share of $15.75 as of December 31, 2019. This marks a 10% decline from the previous estimated NAV per share of $17.50 per share as of December 31, 2018. Previously, Healthcare Trust lowered its annual distribution rate from $1.45 to $0.85 per share on March 1, 2018, after lowering distributions and previously from $1.70 per share to $1.45 per share in 2017.
But shares of Healthcare Trust, which initially sold for $25.00/share, may be worth even less, and have reportedly changed hands in the limited and illiquid secondary market at prices of between $7.75 and $8.25 a share as of the date of this writing. Unfortunately for many investors in Healthcare Trust, it would appear that investors who attempt to exit their illiquid investment will incur a substantial loss.